Shares in the penny stock of Intelligent Living Corp. (OTCBB: ILVC) gained 30% in the last trading session to close at $0.130 on volume of 216,339. ILVC is being pumped this week but the percentage gains could be deceiving considering the historical trend of this cheap stock.
ILVC, a leading provider of green building solutions, is ...
Continue Reading →
Shares in two hot penny stocks are expected to continue to rally on Monday; Herborium Group Inc. (PINKSHEETS: HBRM) and Godfather Media Inc (PINKSHEETS: GDFM).
The penny stock of Herborium Group Inc. (HBRM) closed up 41.18% at $0.0144 on volume of 125,285,282, $1,703,546 worth of shares on 1,370 executed trades. Shares in the penny stock of Godfather Media Inc. (
Continue Reading →
8
Share
APR
Shares in the highly promoted hot penny stock of Sunpeaks Ventures, Inc. (OTCBB: SNPK) could soon begin to follow the path of North Springs Resources (NSRS). Sunpeaks Ventures share price climbed to its highest level last week at $1.13 in the SNPK penny stock. The company announced during the long weekend together with its blah ...
The following 4 penny stocks were within the top 10 in volume traded today, January 11, 2012, on the Over-The-Exchange (OTCBB) which allowed for a true opportunity for a penny stock trader to buy/sell. The other 6 stocks in the top 10 would not be viable options for penny stock traders to involve themselves with. Below them are a ...
Continue Reading →
The following 4 penny stocks were within the top 10 in volume traded yesterday, January 9, 2012, which allowed for a true opportunity for a penny stock trader to buy/sell. The other 6 stocks in the top 10 would not be viable options for penny stock traders to involve themselves with.
Aqualiv Technologies, Inc. (OTCBB: AQLV.OB)
Advanced Cell Technology, Inc. (OTCBB: ACTC)
Advanced Cell Technology, Inc. is a biotechnology company. Millions of people globally depend on ACTC’s development of cellular therapies for the treatment of diseases and conditions. To bring patient-specific therapies from the laboratory to the patient, ACTC applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine.
